missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ CD14 Antibody (atibuclimab) - Chimeric, IgG4SP, Novus Biologicals™
Human Monoclonal Antibody
213.00 € - 920.00 €
Specifications
| Antigen | CD14 |
|---|---|
| Clone | atibuclimab |
| Applications | Flow Cytometry, ELISA, Functional Assay |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
30048268
|
Novus Biologicals™
NBP3-28217-100ug |
100 μg |
326.00 €
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30044098
|
Novus Biologicals™
NBP3-28217-1mg |
1 mg |
920.00 €
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30048432
|
Novus Biologicals™
NBP3-28217-50ug |
50 μg |
213.00 €
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
CD14 Monoclonal antibody specifically detects CD14 in Human samples. It is validated for Flow Cytometry,ELISA,Functional AssaySpecifications
| CD14 | |
| Flow Cytometry, ELISA, Functional Assay | |
| Unconjugated | |
| Human | |
| Adaptive Immunity, Apoptosis, Asthma, Biologically Active Proteins, Cancer, Cell Biology, Cytokine Research, Immunology, Innate Immunity, Myeloid Cell Markers, Stem Cell Markers | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| CD14 antigen, CD14 molecule, monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein | |
| CD14 | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. |
| atibuclimab | |
| Monoclonal | |
| Purified | |
| RUO | |
| Human | |
| P08571 | |
| 929 | |
| IgG4 | |
| Protein A purified | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title